Skip to main content
AMNAMN Healthcare Services IncSell6.1·$32.89-0.54%
SellModerate Confidence
Investment thesis

AMN's exceptional revenue growth and solid recent earnings execution stand out, but a quality score below the required threshold, overbought momentum, and bearish insider selling warrant caution.

Thesis pillars

  • Industry Leading Revenue GrowthStable
  • Quality Below Required FloorDeteriorating
  • Overbought Momentum ConditionDeteriorating
  • +2 more pillars — see the Why tab for full reasoning

Full reasoning →

Open full analysis

AMN Healthcare Services Inc (AMN) Stock Analysis

Catalyst-Driven edge

SellVALUE-TRAP 1/5ValueGrowthModerate Confidence

Healthcare · Medical Care Facilities

Sell if holding. Engine safety override at $32.89: Quality below floor (2.7 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 6.1/10. Specifically: High short interest: 11%; Below-average business quality; Negative price momentum.

AMN Healthcare Services is a leading provider of total talent solutions for the U.S. healthcare sector, offering nurse/physician/allied-health staffing, managed services programs, vendor management systems, language interpretation, and workforce technology like its WorkWise... Read more

$32.89-15.7% A.UpsideScore 6.1/10#10 of 36 Medical Care Facilities
QualityF-score5 / 9FCF yield52.64%
Stop $30.59Target $35.54(resistance)A.R:R -1.4:1
Analyst target$31.86-3.1%7 analysts
$35.54our TP
$32.89price
$31.86mean
$22
$40

Sell if holding. Engine safety override at $32.89: Quality below floor (2.7 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 6.1/10. Specifically: High short interest: 11%; Below-average business quality; Negative price momentum. Chart setup: No clear chart pattern; technical signals are mixed. Score 6.1/10, moderate confidence.

Passes 4/8 gates (clean insider activity, news boost analyst 0.50, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio. Suitability: aggressive.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-07-25

Recent Developments — AMN Healthcare Services Inc

Generated 2026-07-25T14:12:23Z.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Aug 6, 202612d to earnings· next earnings call

Thesis

Rewards
Recent Analyst detected in news
Risks
Target reached (-15.7% upside)
Quality below floor (2.7 < 4.0)

Key Metrics

P/E (TTM)
P/E (Fwd)30.4
Mkt Cap$1.3B
EV/EBITDA5.1
Profit Mgn-0.9%
ROE-4.5%
Rev Growth99.9%
Beta0.41
DividendNone
Rating analysts13

Quality Signals

Piotroski F5/9

Options Flow

P/C0.50bullish
IV79%elevated

Concentration Risks(10-K Item 1A)

  • LOWCustomerKaiser Foundation Hospitals22%
    10-K Item 1A: 'Kaiser Foundation Hospitals (and its affiliates) (collectively, “Kaiser”) comprised approximately 22% of our consolidated revenue in 2025.'

Material Events(8-K, last 90d)

  • 2026-05-04Item 5.02LOW
    Shareholders approved Amendment No. 1 to the AMN Healthcare 2025 Equity Plan at the May 1, 2026 Annual Meeting, previously approved by the Board subject to shareholder vote. Routine compensatory plan item; no officer or director departure involved.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

2 floor-breakers·1 ceiling hit

Unprofitable operations — net margin -0.9%. Quality floor flags this regardless of sector context.static

Roe
0.0
Net Margin
0.0
Gross Margin
1.5
Roa
2.3
Operating Margin
3.4
Moat
4.2
Current Ratio
4.3
Piotroski F
5.6
No competitive moatQuality concerns

Momentum below the gate floor. Component breakdown shows what dragged the score down.static

Macd
0.0
Volume
0.5
Obv
1.0
Ma Position
6.0
Rsi
7.5
Uptrend pullback (RSI 40) - buy opportunityVolume distribution (falling OBV)Above 200-day MA
GatesMomentum 3.0<4.5A.R:R -1.4=NEGATIVEExecutive change: officer departure/appointmentEARNINGS PROXIMITY 12d<=14d (soft)Insider activity: OKNEWS BOOST ANALYST 0.50SEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Aggressive
RSI
40 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $30.85Resistance $36.27

Price Targets

$31
$36
A.Upside-15.7%
A.R:R-1.4:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Target reached (-15.7% upside)
! Quality below floor (2.7 < 4.0)
! momentum at 3.0 (below the engine's 4.5 threshold)

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-08-06 (12d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is AMN stock a buy right now?

Sell if holding. Engine safety override at $32.89: Quality below floor (2.7 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 6.1/10. Specifically: High short interest: 11%; Below-average business quality; Negative price momentum. Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $30.59. Score 6.1/10, moderate confidence.

What is the AMN stock price target?

Take-profit target: $35.54 (-15.7% upside). Prior stop was $30.59. Stop-loss: $30.59.

What are the risks of investing in AMN?

Target reached (-15.7% upside); Quality below floor (2.7 < 4.0).

Is AMN overvalued or undervalued?

AMN Healthcare Services Inc trades at a P/E of N/A (forward 30.4). TrendMatrix value score: 7.1/10. Verdict: Sell.

What do analysts say about AMN?

13 analysts cover AMN with a consensus score of 3.5/5. Average price target: $32.

What does AMN Healthcare Services Inc do?AMN Healthcare Services is a leading provider of total talent solutions for the U.S. healthcare sector, offering...

AMN Healthcare Services is a leading provider of total talent solutions for the U.S. healthcare sector, offering nurse/physician/allied-health staffing, managed services programs, vendor management systems, language interpretation, and workforce technology like its WorkWise platform and AMN Passport app (340,000+ users). The company had 2,664 corporate team members as of December 31, 2025 and averaged about 8,722 nurses/allied professionals in Q4 2025, with Kaiser Foundation Hospitals its largest client at approximately 22% of 2025 consolidated revenue.

Related stocks: NUTX (Nutex Health Inc.) · UHS (Universal Health Services, Inc.) · SRTA (Strata Critical Medical, Inc.) · ARDT (Ardent Health, Inc.) · TOI (The Oncology Institute, Inc.)
Home Stocks AMN

Latest news

Latest News

Benzinga3d agoAnalyst